Treatment Plan for Substance Use Disorder / Addiction
What Is a Treatment Plan for Substance Use Disorder?
A treatment plan for Substance Use Disorder (SUD) is a clinical document that specifies measurable goals, evidence-based interventions, and progress benchmarks for clients diagnosed with problematic patterns of substance use leading to clinically significant impairment or distress. The plan addresses substance use behaviors directly while also targeting the cognitive, behavioral, social, and environmental factors that initiate and maintain use.
SUDs are coded in the ICD-10 under F10-F19 by substance class: F10.x for alcohol, F11.x for opioids, F12.x for cannabis, F13.x for sedatives/hypnotics/anxiolytics, F14.x for cocaine, F15.x for other stimulants (including methamphetamine), F16.x for hallucinogens, F17.x for nicotine, F18.x for inhalants, and F19.x for multiple/other substances. The fourth and fifth characters specify the clinical condition: .10 for abuse (mild use disorder), .20 for uncomplicated dependence (moderate-severe use disorder), .21 for dependence in remission, and additional codes for intoxication, withdrawal, and substance-induced disorders. Proper coding on the treatment plan reflects the severity of the disorder and the current clinical status.
An effective SUD treatment plan operates from the understanding that substance use disorders are chronic, relapsing conditions influenced by neurobiological changes, psychological patterns, social context, and environmental factors. The plan must therefore extend beyond simply stopping substance use to address the full ecology of recovery: coping skills, social support, employment, housing, co-occurring mental health conditions, and the development of a recovery-supportive lifestyle. This broader framework is captured in the concept of recovery capital — the internal and external resources a person can draw upon to initiate and sustain recovery.
When You Need It
- After a comprehensive substance use assessment that includes substance use history, pattern and severity of current use, withdrawal risk, prior treatment episodes, and readiness for change
- When beginning outpatient or intensive outpatient SUD treatment following assessment and, if indicated, medically managed detoxification
- When a client steps down from residential or inpatient treatment to outpatient care and needs a continuing care plan
- When an existing treatment plan expires and 90-day renewal requires updated progress data, substance use frequency, and screening scores
- When a court, probation officer, or employer mandates treatment and requires a documented treatment plan
- When the client's substance use pattern changes (new substance, escalation, relapse after a period of abstinence) and goals require modification
- When insurance or managed care requires documentation of medical necessity for continued treatment
Key Components
Diagnosis, Substance Use Pattern, and Risk Assessment
Document the specific ICD-10 code(s), the substance(s) used, route of administration, frequency and quantity of recent use, date of last use, withdrawal history and risk, prior treatment episodes and outcomes, and current readiness for change (precontemplation, contemplation, preparation, action, maintenance). Include results from validated screening instruments (AUDIT, DAST-10, CAGE) and relevant medical findings. Risk assessment should cover overdose history, IV drug use, co-occurring medical conditions (hepatitis C, HIV), and driving under the influence.
Treatment Goals
SUD treatment plans should address these interconnected domains:
- Substance use reduction or abstinence — Decreasing or eliminating use of the identified substance(s), with targets matched to the client's stage of change and clinical severity
- Coping skills and relapse prevention — Developing cognitive, behavioral, and interpersonal skills to manage triggers, cravings, and high-risk situations without substance use
- Recovery capital development — Building and strengthening the social supports, daily structure, employment, housing, and health practices that sustain long-term recovery
- Co-occurring condition management — Addressing mental health conditions, medical conditions, and psychosocial stressors that interact with substance use
Evidence-Based Interventions
- Motivational Interviewing (MI) — Explores and resolves ambivalence about change; particularly effective in early treatment and with clients who are not yet committed to abstinence
- Cognitive Behavioral Therapy for SUD (CBT-SUD) — Identifies and modifies substance-related cognitions, teaches coping skills for high-risk situations, and develops relapse prevention strategies
- Contingency Management (CM) — Provides tangible reinforcement for verified abstinence or treatment attendance; strongest evidence for stimulant use disorders
- Relapse Prevention (RP) — Identifies high-risk situations, develops coping strategies, addresses the abstinence violation effect, and builds a lifestyle balance that reduces relapse vulnerability
- 12-Step Facilitation (TSF) — Structured approach to engaging clients with mutual support groups (AA, NA, SMART Recovery)
Treatment Plan: Alcohol Use Disorder
Client: David M. (pseudonym) Date of Plan: 03/19/2026 Target Review Date: 06/17/2026 (90 days) Diagnosis: Alcohol Use Disorder, moderate (F10.20); Major Depressive Disorder, recurrent, moderate (F33.1) Current AUDIT Score: 28 (high risk/harmful use) Substance Use Pattern: Client reports drinking 6-10 standard drinks of whiskey, 5-6 nights per week, typically beginning at 6pm and continuing until loss of consciousness. Weekend use increases to 12-15 drinks per day. Pattern has been present for approximately 4 years, escalating over the past 18 months. Last drink was 12 days ago; client completed 5-day medical detoxification at County General Hospital prior to initiating outpatient treatment. Two prior treatment episodes (2022 IOP, completed; 2024 residential, left AMA after 10 days). No history of withdrawal seizures. Reports using alcohol to manage depressive symptoms, insomnia, and social anxiety. Stage of Change: Action (committed to abstinence following most recent detoxification; reports "I know I can't moderate, I've tried") Recovery Capital Assessment: Strengths — employed full-time (accommodating employer), owns home, supportive sister, motivated by pending divorce and desire to repair relationship with teenage children. Barriers — primary social network consists of drinking partners, limited sober leisure activities, untreated depression, insomnia.
Goal 1: Achieve and maintain abstinence from alcohol.
Objective 1.1: Client will maintain continuous abstinence from alcohol for the full 90-day treatment plan period, as verified by self-report, collateral from sister, and periodic PEth or EtG testing at clinician's discretion.
Objective 1.2: Client will identify and implement at least 3 effective coping strategies for managing alcohol cravings without use, as demonstrated in session role-plays and reported on a coping skills log, within 6 weeks.
Objective 1.3: Client will develop a written relapse prevention plan that identifies a minimum of 5 personal high-risk situations, 3 coping strategies for each, and an emergency contact list of at least 4 people, within 8 weeks.
Interventions for Goal 1:
- Conduct a detailed functional analysis of the client's drinking pattern — identify triggers (time of day, emotional states, social situations, environmental cues), the sequence of events leading to use, and the perceived positive and negative consequences
- Implement CBT-SUD skills training targeting high-risk situations: drink refusal skills, craving management (urge surfing, distraction, delay), challenging permissive cognitions ("One drink won't hurt," "I deserve it after the week I've had")
- Develop a comprehensive relapse prevention plan using Marlatt's model: identify high-risk situations, develop coping responses, address the abstinence violation effect, and create an emergency plan for lapses
- Coordinate with PCP regarding naltrexone or acamprosate as adjunctive pharmacotherapy for alcohol use disorder; support medication adherence in session
- Administer AUDIT every 30 days to track self-reported severity and risk level
Goal 2: Develop recovery-supportive social network and daily structure.
Objective 2.1: Client will attend a minimum of 3 mutual support group meetings per week (AA, SMART Recovery, or Refuge Recovery) for the duration of the treatment plan period, as documented on a meeting attendance log.
Objective 2.2: Client will identify and engage with a sponsor or recovery mentor within 6 weeks of initiating mutual support group attendance, as reported in session.
Objective 2.3: Client will develop and implement a structured weekly schedule that includes at least 3 sober social or recreational activities, within 8 weeks, as tracked on a weekly activity log.
Interventions for Goal 2:
- Use 12-Step Facilitation protocol to prepare client for mutual support group attendance — address barriers (misconceptions about AA, social anxiety, discomfort with spiritual language), identify local meetings, and process attendance experiences in session
- Explore alternative recovery support options (SMART Recovery, Refuge Recovery, LifeRing) for clients who do not connect with 12-step programs
- Conduct a social network assessment — map current relationships by their support for recovery versus risk for relapse, and develop a plan for increasing recovery-supportive contacts while managing high-risk relationships
- Use behavioral activation to identify and schedule sober leisure activities that provide the social connection and stress relief previously obtained through drinking
- Assist client in developing a structured daily routine that reduces unstructured time — a primary relapse risk factor
Goal 3: Reduce depressive symptoms that interact with alcohol use.
Objective 3.1: Client will reduce PHQ-9 score from 18 (moderately severe) to 9 or below (mild) within 12 weeks, as assessed biweekly by clinician.
Objective 3.2: Client will implement a daily sleep hygiene routine and reduce sleep onset latency from 90 minutes to 30 minutes or less on at least 5 of 7 nights per week, as tracked on a sleep diary, within 8 weeks.
Objective 3.3: Client will engage in at least 3 values-aligned activities per week outside of work (e.g., attending children's events, exercising, pursuing a hobby), as tracked on a behavioral activation log, within 10 weeks.
Interventions for Goal 3:
- Administer PHQ-9 biweekly to distinguish substance-induced depressive symptoms (which typically improve with sustained abstinence) from independent MDD requiring targeted intervention
- Implement behavioral activation for depression — schedule pleasant and mastery activities, monitor mood in relation to activity level, and address withdrawal and avoidance patterns
- Apply cognitive restructuring to depressive cognitions, particularly those that increase relapse risk ("I've already ruined everything," "What's the point of staying sober")
- Develop sleep hygiene protocol (consistent sleep-wake times, stimulus control, no screens 1 hour before bed, relaxation routine) to address insomnia without reliance on alcohol or sedating medications
- Coordinate with psychiatrist regarding antidepressant medication — if depressive symptoms persist after 4-6 weeks of abstinence, this supports an independent MDD diagnosis warranting pharmacotherapy
Session Frequency: Individual therapy twice weekly for weeks 1-4 (CPT 90837), stepping down to weekly for weeks 5-12; group therapy once weekly (CPT 90853) Modality: Cognitive Behavioral Therapy for SUD with Motivational Interviewing and Relapse Prevention Estimated Duration of Treatment: 16-20 individual sessions plus ongoing group
This is a sample for educational purposes only — not real patient data.
How to Write It Step by Step
Step 1: Assess readiness for change and match goals accordingly. The stages of change model is not a relic — it is clinically essential for SUD treatment planning. A client in precontemplation who is mandated to treatment needs goals focused on exploring the impact of substance use and building motivation, not goals demanding immediate abstinence. A client in the action stage who has just completed detox needs goals focused on maintaining abstinence, developing coping skills, and building recovery capital. Mismatching goals to the client's stage of change produces plans that look good on paper but fail in practice because the client is not engaged.
Step 2: Conduct a thorough substance use assessment beyond screening scores. Document the specific substances, amounts, frequency, route of administration, age of onset, pattern of escalation, prior quit attempts, longest period of abstinence and what supported it, prior treatment episodes and why they did or did not work, withdrawal history, and overdose history. This information shapes the goals, determines appropriate level of care per ASAM criteria, and identifies what has worked and what has not in the past.
Step 3: Assess recovery capital. Recovery capital includes internal assets (motivation, coping skills, self-efficacy, physical health) and external assets (social support, employment, housing, financial resources, community connections). Clients with low recovery capital need treatment plans that prioritize building these resources — a brilliant relapse prevention plan is irrelevant if the client is homeless and surrounded by active users. Include at least one goal targeting recovery capital development.
Step 4: Address co-occurring conditions in the same plan. Approximately 50% of individuals with SUD have a co-occurring mental health disorder. List all diagnoses, write separate goals for each, and specify how you will address the interaction between conditions. "Client uses alcohol to cope with depressive symptoms; treatment will provide alternative coping strategies for depression to reduce reliance on alcohol" demonstrates integrated clinical thinking.
Step 5: Build relapse prevention into the plan from session one. Relapse prevention is not something that happens at the end of treatment — it begins immediately. High-risk situation identification, coping skills development, and emergency planning should appear as objectives from the outset. If a client relapses during treatment, update the plan to address the specific circumstances of the relapse rather than treating it as treatment failure.
Step 6: Specify the frequency and structure of treatment contacts. SUD treatment often involves more than one modality — individual therapy, group therapy, mutual support meetings, case management, medication management. Specify each component, its frequency, and how the components work together. A treatment plan that lists only weekly individual therapy for a client with severe alcohol use disorder who just left detox is likely insufficient in intensity.
Common Mistakes
Requiring abstinence as the only acceptable goal. While abstinence is the safest and most clinically supported goal for most moderate-to-severe SUDs, particularly alcohol and opioid use disorders, a rigid abstinence-only approach can drive away clients who are ambivalent about stopping entirely. Harm reduction goals — reducing quantity, eliminating the most dangerous patterns of use, achieving periods of abstinence — are clinically appropriate for clients in earlier stages of change. Document the client's stated goals, your clinical recommendation, and the plan for revisiting goals as readiness increases.
Ignoring the social and environmental context of use. A treatment plan that focuses exclusively on individual coping skills while ignoring the fact that the client's partner uses, the client lives in a neighborhood with high substance availability, or the client's primary social activities center on drinking will produce limited results. Recovery capital assessment and environmental modification should be core components of every SUD treatment plan.
Writing generic relapse prevention goals without functional analysis. "Client will develop coping skills to avoid relapse" is not a treatment plan goal — it is a wish. Effective relapse prevention begins with a detailed functional analysis of the client's use pattern. What are the specific high-risk situations? What internal states precede use? What are the client's permissive cognitions? What happened in prior relapses? Goals and interventions should target these specific, identified patterns.
Failing to coordinate with other providers. SUD treatment frequently involves prescribers (MAT, psychiatric medications), primary care physicians, case managers, probation officers, and mutual support groups. A treatment plan that does not document these relationships and how coordination will occur suggests siloed treatment. Include the treatment team in the plan and specify communication protocols.
Treating relapse as treatment failure rather than clinical data. A treatment plan that does not anticipate the possibility of relapse and include a protocol for responding to it is incomplete. Relapse during treatment is common and provides valuable clinical information about inadequate coping skills, unaddressed triggers, or insufficient treatment intensity. The plan should specify how relapse will be addressed — immediate reassessment, potential level-of-care change, functional analysis of the relapse episode, and plan modification — rather than resulting in discharge.
Writing a treatment plan right now?
My Clinical Writer helps you build treatment plans from your session details in under 60 seconds.
Try My Clinical Writer Free →myclinicalwriter.ai
Frequently Asked Questions
Related Templates
External Resources
Authoritative references and tools related to this documentation type.
Stop spending hours on documentation
My Clinical Writer uses AI to help you draft clinical notes, treatment plans, and reports in minutes — not hours.
Get Started at myclinicalwriter.ai →